Open Label, Single Dose, Non-randomized Study to Assess the Drug to Drug Interaction of Briakinumab on CYP Substrates.
|ClinicalTrials.gov Identifier: NCT01260844|
Recruitment Status : Withdrawn (Study stopped)
First Posted : December 15, 2010
Last Update Posted : October 21, 2011
Information provided by (Responsible Party):
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Recruitment Status :||Withdrawn|
|Primary Completion Date :||No date given|
|Study Completion Date :||No date given|